NORTH AMERICAN BIOLOGICALS/UNIVAX STOCK-SWAP MERGER CREATES $200 MIL. BLOOD PRODUCTS COMPANY; UNIVAX/CHIRON TO COLLABORATE ON VACCINE-BASED IG PRODUCTS
Executive Summary
A $150 mil. stock-swap merger will unite North American Biologicals Inc., the largest independent supplier of human blood plasma components, and Univax Biologics, which develops vaccines and polyclonal antibodies to treat autoimmune and infectious diseases.